How big is the Home Infusion Therapy Market?

The Home Infusion Therapy Market size is expected to reach USD 24.40 billion in 2024 and grow at a CAGR of 6.5% to reach USD 33.47 billion by 2029. Read More

What is the current Home Infusion Therapy Market size?

In 2024, the Home Infusion Therapy Market size is expected to reach USD 24.40 billion. Read More

Who are the key players in Home Infusion Therapy Market?

B. Braun Melsungen AG, ICU Medical, Becton Dickinson and Company, Option Care Health Inc. and CareCentrix, Inc. are the major companies operating in the Home Infusion Therapy Market. Read More

Which is the fastest growing region in Home Infusion Therapy Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Home Infusion Therapy Market?

In 2024, the North America accounts for the largest market share in Home Infusion Therapy Market. Read More

What years does this Home Infusion Therapy Market cover, and what was the market size in 2023?

In 2023, the Home Infusion Therapy Market size was estimated at USD 22.81 billion. The report covers the Home Infusion Therapy Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Home Infusion Therapy Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Home Infusion Therapy Market Share

Statistics for the 2023 & 2024 Home Infusion Therapy market share, created by Mordor Intelligence™ Industry Reports. Home Infusion Therapy share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Home Infusion Therapy Industry

The market for home infusion therapy is moderately competitive and consists of global as well as several regional players. Due to technological advancements, small and mid-sized companies are focusing on market penetration to grab market share. The major players in the market include B. Braun Melsungen AG, ICU Medica, Becton Dickinson and Company, Option Care Health Inc., and CareCentrix Inc., among others.